financetom
Business
financetom
/
Business
/
Chime set for long-awaited market debut after $864 million US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chime set for long-awaited market debut after $864 million US IPO
Jun 12, 2025 4:20 AM

(Reuters) -Chime is set to debut on the Nasdaq later on Thursday after raising $864 million in its initial public offering, with investors waiting to see whether the digital bank will maintain the recent streak of explosive first-day gains for new listings.

The hotly anticipated debut is being viewed as a bellwether for other IPO candidates in the fintech industry, where valuations have cooled from pandemic-era highs.

"A strong debut could trigger a domino effect, prompting other high-growth firms to accelerate their IPO timelines and position themselves for a window that's starting to reopen," said Kat Liu, vice president at IPOX.

"If well-received, Chime could help reopen the IPO window for other long-delayed unicorns."

Chime and some of its investors sold 32 million shares priced at $27 each. It had earlier marketed a $24 to $26 price range.

The IPO gave the San Francisco-based company a fully diluted valuation of $11.6 billion. It was last valued at $25 billion after a funding round in August 2021.

Chime's major backers include Yuri Milner's DST Global and investment firms General Atlantic and ICONIQ. It has raised $2.65 billion from private investors since its inception, according to PitchBook data.

Digital banks such as Chime have grown rapidly in recent years by offering low-cost, mobile-first financial services that appeal to younger users and underserved consumers.

With features such as no-fee accounts, early access to direct deposits and user-friendly apps, they have positioned themselves as accessible alternatives to traditional banks.

The fintech earns revenue primarily from interchange fees collected when users swipe their debit cards.

Morgan Stanley, Goldman Sachs and J.P. Morgan were the lead underwriters for Chime's IPO.

MARKET THAW DRAWS IPO HOPEFULS

Soaring interest rates and recession fears since the 2021 IPO boom have hit valuations and investor demand for new issues, forcing many private companies to delay their IPO plans. But some high-growth firms are cautiously testing the waters again.

Circle, the stablecoin issuer that went public last week, has seen its stock gain fourfold from its IPO price. Space tech firm Voyager's shares more than doubled on their debut on Wednesday.

However, some analysts cautioned against excessive optimism, warning that uncertainty around trade negotiations by President Donald Trump's administration could weigh on the broader recovery.

"While this is clearly a strong IPO window now, there is no guarantee it will continue," said Samuel Kerr, head of equity capital markets at Mergermarket.

"Investors and issuers have made use of the tariff pause to do deals but there is still broad uncertainty."

Crypto exchange Gemini, buy-now-pay-later firm Klarna, AI chipmaker Cerebras and medical supplies company Medline are among the most closely watched names in the current IPO pipeline.

(Reporting by Niket Nishant and Manya Saini in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Musk's xAI Set to Secure $15 Billion Funding Round in December
Market Chatter: Musk's xAI Set to Secure $15 Billion Funding Round in December
Nov 25, 2025
12:04 PM EST, 11/25/2025 (MT Newswires) -- Tesla (TSLA) Chief Executive Elon Musk's artificial intelligence startup xAI is expected to close a $15 billion fundraising round next month at a pre-money valuation of $230 billion, CNBC reported Tuesday, citing unnamed sources familiar with the matter. Investors have until the end of the day on Tuesday to secure their allocation, and...
Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk
Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk
Nov 25, 2025
The U.S. Food and Drug Administration (FDA) on Tuesday approved dosing in Sarepta Therapeutics Inc.’s Cohort 8 of ENDEAVOR (Study 9001-103). • SRPT shares are advancing steadily. Get the market research here. The purpose of Cohort 8 is to evaluate the use of an enhanced immunosuppressive regimen as part of treatment with Elevidys (delandistrogene moxeparvovec-rokl) for non-ambulant (patients who cannot...
Honeywell International Signs Deal With Dangote to Supply Services for Petroleum Capacity Expansion in Nigeria
Honeywell International Signs Deal With Dangote to Supply Services for Petroleum Capacity Expansion in Nigeria
Nov 25, 2025
12:05 PM EST, 11/25/2025 (MT Newswires) -- Honeywell International ( HON ) has entered into a partnership with Dangote Group to support the Nigerian company's expansion of its petroleum refinery to 1.4 million barrels per day by 2028, the companies said in separate statements Tuesday. Under the agreement, Honeywell ( HON ) will supply the refinery with catalysts, equipment, and...
Update: Market Chatter: Barrick Mining to Pay $428.9 Million in Mali Mine Settlement
Update: Market Chatter: Barrick Mining to Pay $428.9 Million in Mali Mine Settlement
Nov 25, 2025
12:07 PM EST, 11/25/2025 (MT Newswires) -- (Updates with company response in fourth paragraph.) Barrick Mining ( B ) agreed to pay 244 billion CFA francs ($428.9 million) to Mali to settle a two-year dispute over the company's Loulo-Gounkoto gold mining operations, Bloomberg reported Tuesday, citing people familiar with the matter. The company will pay 144 billion CFA francs within...
Copyright 2023-2026 - www.financetom.com All Rights Reserved